Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ER overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

ER overexpression	HER2 Positive Breast Cancer	ER overexpression	HER2 Positive Breast Cancer	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3
ER overexpression	Estrogen Receptor Positive Breast Cancer	ER overexpression	Estrogen Receptor Positive Breast Cancer	tamoxifen Resistant: C3 – Early Trials tamoxifen Resistant : C3	tamoxifen Resistant: C3 – Early Trials tamoxifen Resistant : C3
ER overexpression	HER2 Positive Breast Cancer	ER overexpression	HER2 Positive Breast Cancer	ado-trastuzumab emtansine Resistant: C3 – Early Trials ado-trastuzumab emtansine Resistant : C3	ado-trastuzumab emtansine Resistant: C3 – Early Trials ado-trastuzumab emtansine Resistant : C3